Atlas Trials

Bortezomib, Ifosfamide, and Vinorelbine Tartrate in Treating Young Patients With Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Therapy

Clinical trial NCT00381940 · COMPLETED

Trial details

NCT number
NCT00381940
Sponsor
National Cancer Institute (NCI)
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Adult Lymphocyte Depletion Hodgkin LymphomaAdult Lymphocyte Predominant Hodgkin LymphomaAdult Mixed Cellularity Hodgkin LymphomaAdult Nodular Lymphocyte Predominant Hodgkin LymphomaAdult Nodular Sclerosis Hodgkin LymphomaChildhood Lymphocyte Depletion Hodgkin LymphomaChildhood Lymphocyte Predominant Hodgkin LymphomaChildhood Mixed Cellularity Hodgkin LymphomaChildhood Nodular Lymphocyte Predominant Hodgkin LymphomaChildhood Nodular Sclerosis Hodgkin LymphomaRecurrent Adult Hodgkin LymphomaRecurrent/Refractory Childhood Hodgkin Lymphoma
Start date
2007-01-01
Primary completion
2008-06-01
Enrollment
26

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.